Shahrokh Shariat

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Shahrokh Shariat
Born (1973-09-20) September 20, 1973 (age 48)
NationalityAustrian
EducationUniversity of Vienna
Baylor College of Medicine
University of Texas Southwestern Medical Center
Memorial Sloan-Kettering Cancer Center
Alma materUniversity of Vienna
Baylor College of Medicine
University of Texas Southwestern Medical Center
Memorial Sloan-Kettering Cancer Center
OccupationPhysician, Surgeon, Oncologist, Urologist
Website

Shahrokh François Shariat (born September 20, 1973) is currently professor and chairman of the department of urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria. He is also adjunct professor of urology at Weill Cornell Medical Center, New York, NY; adjunct professor of urology at the University of Texas Southwestern Medical Center, Dallas, TX, USA; adjunct professor of urology at the Faculty of Medicine, Charles University, Prague, CZ; adjunct professor of urology at I.M. Sechenov First Moscow State Medical University, Moscow, RU; honorary professor of urology, University of Jordan, Amman, JO; and doctor honoris causa, Carol Davila University of Medicine and Pharmacy, Bucharest, RO. He has published more than 1400 peer-reviewed research papers, more than 500 non-peer-reviewed papers, and 26 book chapters. He has been voted as the most influential urologist in 2020 and also the most cited PCa researcher in the German speaking area.

Shahrokh Shariat is the recipient of various national and international awards. He has, for example, received the prestigious Matula Award from the European Urological Association and the Gold Cystoscope 2017 from the American Urological Association. He is a member of 25 academic societies and editorial board of 26 scientific journals.

He is an editorial board member of European Urology, BJU International, World Journal of Urology, Current Opinion in Urology (editor in chief), and Immunotherapy among others. He heads a medical charity for refugees and is on the medical advisory board for two other charities. He joined in 2010 the New York Presbyterian Hospital and Weill Cornell Medical Center in New York, NY.

Areas of Focus[edit]

Shahrokh Shariat specializes in treating urologic malignancies. He has published more than 920 research papers and is the holder of four patents stemming from his research into prostate cancer and bladder cancer. Dr. Shariat also reviews grant proposals for cancer research foundations and reviews paper submissions for many journals. He has been repeatedly recognized as one of the leading uro-oncologist worldwide winning many awards from diverse societies and patient self-help groups.

Dr. Shariat's research focuses on the following areas:

  1. Translational research in robotic prostatectomy and prostate cancer
  2. Translational research in bladder cancer and upper tract urothelial carcinoma
  3. Gene, vaccine and immuno therapies for urologic diseases with focus on bladder and prostate cancers
  4. Minimal invasive instrumental treatment modalities for BPH and prostate cancer.

External links[edit]